| Epithelial sodium channels in the adult lung--important modulators of pulmonary health and disease. | |
| | |
MedLine Citation:
|
PMID: 18269193 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Absorption of excess fluid from the airways and alveolar lumen requires active vectorial transepithelial transport of sodium ions (Na+) by alveolar type II and possibly type I cells. The rate-limiting step in this process is the activity of the heterotrimeric apical membrane epithelial Na+ channel (ENaC). Pharmacologic inhibitors and genetic manipulations that disrupt Na+ transport result in fluid accumulation within the lung and failure of gas exchange. The importance of Na+ transport in the lung is also demonstrated in conditions such as ARDS, where abnormal absorption of Na+ contributes to the pathophysiology of pulmonary disease. ENaC expression and function is influenced by diverse factors, such as oxygen tension, glucocorticoids, and cytoskeletal proteins. In addition, ENaC dysfunction has been shown to be induced by purinergic nucleotide activation of P2Y receptors (in paramyxoviral bronchiolitis) and reactive species (in acute lung injury). Finally, beta-adrenergic agonists have been shown experimentally to reverse defects in ENaC function, and improve hypoxemia and pulmonary edema, and may provide a novel therapeutic modality for ARDS, although some viral lung pathogens appear to induce insensitivity to their actions. |
| | |
Authors:
|
Ian C Davis; Sadis Matalon |
Related Documents
:
|
18565993 - Role of the amino and carboxy termini in isoform-specific sodium channel variation. 9142843 - Electrogenic li+/li+ exchange mediated by the na+-k+ pump in rabbit cardiac myocytes. 21525363 - Optogenetic photochemical control of designer k+ channels in mammalian neurons. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Review |
Journal Detail:
|
Title: Advances in experimental medicine and biology Volume: 618 ISSN: 0065-2598 ISO Abbreviation: Adv. Exp. Med. Biol. Publication Date: 2007 |
Date Detail:
|
Created Date: 2008-02-13 Completed Date: 2008-03-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0121103 Medline TA: Adv Exp Med Biol Country: United States |
Other Details:
|
Languages: eng Pagination: 127-40 Citation Subset: IM |
Affiliation:
|
Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
therapeutic use Adult Epithelial Sodium Channel / physiology* Humans Lung / metabolism*, physiopathology Lung Diseases / drug therapy, etiology* Risk Factors Sodium / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
HL31197/HL/NHLBI NIH HHS; HL51173/HL/NHLBI NIH HHS; RR17626/RR/NCRR NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Epithelial Sodium Channel; 7440-23-5/Sodium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hypoxia and placental remodelling.
Next Document: Lung interstitial pressure and structure in acute hypoxia.